Keyt BA - Search Results

1

Antibody discovery via multiplexed single cell characterization.

Harriman WD, Collarini EJ, Sperinde GV, Strandh M, Fatholahi MM, Dutta A, Lee Y, Mettler SE, Keyt BA, Ellsworth SL, Kauvar LM. Harriman WD, et al. Among authors: keyt ba. J Immunol Methods. 2009 Feb 28;341(1-2):135-45. doi: 10.1016/j.jim.2008.11.009. Epub 2008 Dec 16. J Immunol Methods. 2009. PMID: 19087879 Free PMC article.

2

Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients.

Collarini EJ, Lee FE, Foord O, Park M, Sperinde G, Wu H, Harriman WD, Carroll SF, Ellsworth SL, Anderson LJ, Tripp RA, Walsh EE, Keyt BA, Kauvar LM. Collarini EJ, et al. Among authors: keyt ba. J Immunol. 2009 Nov 15;183(10):6338-45. doi: 10.4049/jimmunol.0901373. Epub 2009 Oct 19. J Immunol. 2009. PMID: 19841167

3

A sensitive fluorometric enzyme-linked immunosorbent assay that measures vascular endothelial growth factor165 in human plasma.

Rodriguez CR, Fei DT, Keyt B, Baly DL. Rodriguez CR, et al. J Immunol Methods. 1998 Oct 1;219(1-2):45-55. doi: 10.1016/s0022-1759(98)00131-8. J Immunol Methods. 1998. PMID: 9831387

4

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Strohl WR, Ku Z, An Z, Carroll SF, Keyt BA, Strohl LM. Strohl WR, et al. Among authors: keyt ba. BioDrugs. 2022 May;36(3):231-323. doi: 10.1007/s40259-022-00529-7. Epub 2022 Apr 27. BioDrugs. 2022. PMID: 35476216 Free PMC article. Review.

5

Structure, Function, and Therapeutic Use of IgM Antibodies.

Keyt BA, Baliga R, Sinclair AM, Carroll SF, Peterson MS. Keyt BA, et al. Antibodies (Basel). 2020 Oct 13;9(4):53. doi: 10.3390/antib9040053. Antibodies (Basel). 2020. PMID: 33066119 Free PMC article. Review.

6

Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.

Keck RG, Berleau L, Harris R, Keyt BA. Keck RG, et al. Among authors: keyt ba. Arch Biochem Biophys. 1997 Aug 1;344(1):103-13. doi: 10.1006/abbi.1997.0145. Arch Biochem Biophys. 1997. PMID: 9244387

7

The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.

Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, Ferrara N. Keyt BA, et al. J Biol Chem. 1996 Mar 29;271(13):7788-95. doi: 10.1074/jbc.271.13.7788. J Biol Chem. 1996. PMID: 8631822 Free article.

8

The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.

Muller YA, Christinger HW, Keyt BA, de Vos AM. Muller YA, et al. Among authors: keyt ba. Structure. 1997 Oct 15;5(10):1325-38. doi: 10.1016/s0969-2126(97)00284-0. Structure. 1997. PMID: 9351807 Free article.

9

Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection.

Yang R, Bunting S, Ko A, Keyt BA, Modi NB, Zioncheck TF, Ferrara N, Jin H. Yang R, et al. Among authors: keyt ba. J Pharmacol Exp Ther. 1998 Jan;284(1):103-10. J Pharmacol Exp Ther. 1998. PMID: 9435167

10

Crystallization of the receptor binding domain of vascular endothelial growth factor.

Christinger HW, Muller YA, Berleau LT, Keyt BA, Cunningham BC, Ferrara N, de Vos AM. Christinger HW, et al. Among authors: keyt ba. Proteins. 1996 Nov;26(3):353-7. doi: 10.1002/(SICI)1097-0134(199611)26:3<353::AID-PROT9>3.0.CO;2-E. Proteins. 1996. PMID: 8953654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page